Microscopic Polyangiitis: Clinical Aspects

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. , 2010, Arthritis and rheumatism.

[2]  K. Jindal,et al.  Management of idiopathic crescentic and diffuse proliferative glomerulonephritis: evidence-based recommendations. , 1999, Kidney international. Supplement.

[3]  N. Wig,et al.  Microscopic polyangiitis associated with antiphospholipid syndrome. , 1999, Rheumatology.

[4]  E. Hachulla,et al.  Serial measurements of antineutrophil cytoplasmic autoantibodies in patients with systemic vasculitis. , 1999, The American journal of medicine.

[5]  J. Amouroux,et al.  Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. , 1999, Arthritis and rheumatism.

[6]  C. Kallenberg,et al.  Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis. , 1998, Journal of the American Society of Nephrology : JASN.

[7]  Tidman,et al.  Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975–95: organ involvement, anti‐neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies , 1998, Journal of internal medicine.

[8]  M. Haubitz,et al.  Cyclosporin for the prevention of disease reactivation in relapsing ANCA-associated vasculitis. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  J. Ranstam,et al.  Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement. , 1998, Journal of the American Society of Nephrology : JASN.

[10]  B. Hoen,et al.  A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis. , 1997, Arthritis and rheumatism.

[11]  D. Adu,et al.  Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. , 1997, QJM : monthly journal of the Association of Physicians.

[12]  C. Gordon,et al.  Damage occurs early in systemic vasculitis and is an index of outcome. , 1997, QJM : monthly journal of the Association of Physicians.

[13]  F. Woude,et al.  Mycophenolate mofetil for systemic vasculitis and IgA nephropathy , 1997, The Lancet.

[14]  C. Gordon,et al.  Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. , 1997, Arthritis and rheumatism.

[15]  F Lhote,et al.  Antineutrophil cytoplasmic antibodies, abnormal angiograms and pathological findings in polyarteritis nodosa and Churg-Strauss syndrome: indications for the classification of vasculitides of the polyarteritis Nodosa Group. , 1996, British journal of rheumatology.

[16]  G. Hunder,et al.  Long-term survival of patients with Wegener's granulomatosis from the American College of Rheumatology Wegener's Granulomatosis Classification Criteria Cohort. , 1996, The American journal of medicine.

[17]  D. Scott,et al.  Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis. , 1996, Arthritis and rheumatism.

[18]  Guy Hoffman,et al.  Cyclophosphamide-Induced Cystitis and Bladder Cancer in Patients with Wegener Granulomatosis , 1996, Annals of Internal Medicine.

[19]  W. Gross,et al.  Treatment of anti‐neutrophil cytoplasmic antibody (ANCA)‐associated systemic vasculitis with high‐dose intravenous immunoglobulin , 1995, Clinical and experimental immunology.

[20]  A. Howie,et al.  Vasculitis in the kidney , 1995 .

[21]  Guy Hoffman,et al.  An analysis of forty-two Wegener's granulomatosis patients treated with methotrexate and prednisone. , 1995, Arthritis and rheumatism.

[22]  E. Badley,et al.  Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. , 1994, Arthritis and rheumatism.

[23]  R. Moots,et al.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. , 1994, QJM : monthly journal of the Association of Physicians.

[24]  D. Scott,et al.  Classification and epidemiology of systemic vasculitis. , 1994, British journal of rheumatology.

[25]  M. Heller,et al.  Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis. , 1994, Arthritis and rheumatism.

[26]  D. Adu,et al.  Relapses in patients with a systemic vasculitis. , 1993, The Quarterly journal of medicine.

[27]  E. Ritz,et al.  In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis , 1993 .

[28]  A. Douglas,et al.  Wegener's granuloma. A series of 265 British cases seen between 1975 and 1985. A report by a sub-committee of the British Thoracic Society Research Committee. , 1992, The Quarterly journal of medicine.

[29]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[30]  Guy Hoffman,et al.  Wegener Granulomatosis: An Analysis of 158 Patients , 1992, Annals of Internal Medicine.

[31]  C. Pusey,et al.  Plasma exchange in focal necrotizing glomerulonephritis without anti-GBM antibodies. , 1991, Kidney international.

[32]  M. Davies,et al.  Treatment of systemic vasculitis with pooled intravenous immunoglobulin , 1991, The Lancet.

[33]  Guy Hoffman,et al.  Treatment of Wegener's granulomatosis with intermittent high-dose intravenous cyclophosphamide. , 1990, The American journal of medicine.

[34]  J. Feehally,et al.  Systemic Vasculitis in the 1980s—Is There an Increasing Incidence of Wegener's Graanulomatosis and Microscopic Polyarteritis? , 1990, Journal of the Royal College of Physicians of London.

[35]  D. Scott,et al.  Polyarteritis and the kidney. , 1987, The Quarterly journal of medicine.

[36]  C. Savage,et al.  Microscopic polyarteritis: presentation, pathology and prognosis. , 1985, The Quarterly journal of medicine.

[37]  D. Scott,et al.  Intravenous cyclophosphamide plus methylprednisolone in treatment of systemic rheumatoid vasculitis. , 1984, The American journal of medicine.

[38]  R PLATT,et al.  The kidney in periarteritis nodosa. , 1948, The Quarterly journal of medicine.

[39]  T. Schleiffer,et al.  Clinical course and symptomatic prediagnostic period of patients with Wegener's granulomatosis and microscopic polyangiitis. , 1998, Renal failure.

[40]  O. Lortholary,et al.  Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. , 1996, Medicine.

[41]  R. Falk,et al.  Treatment response and relapse in antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis. , 1996, Journal of the American Society of Nephrology : JASN.

[42]  C. Kallenberg,et al.  Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis , 1994, Annals of Internal Medicine.

[43]  V. D’Agati,et al.  Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. , 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.